Enter your number to get our free mobile app

Rochester, MN (KROC-AM News) - The Mayo Clinic has announced it has been awarded an over $22 million grant to fund research into pancreatic cancer.

A news release says the funding from the Centene Charitable Foundation will focus on patient-centered solutions using artificial intelligence and advanced diagnostics for early detection.

"Advancing medical research through innovative technology and patient-centered solutions is deeply aligned with Centene's purpose-driven work. Cancer does not discriminate by age, race or status, and the work of medical researchers at Mayo Clinic is vital to improving the health of our communities," says Michael F. Neidorff, chairman, president and CEO of Centene. "Together, we can address the unique needs of individuals impacted by pancreatic cancer."

The Mayo Clinic says a research team will build algorithms that will identify people at high risk of pancreatic cancer and enable image-based identification of early cancer and precancerous lesions. The project will also strive to discover and validate new molecular biomarkers for the illness and develop a collaborative clinical model for caring for people facing a high risk of pancreatic cancer.

Courtesy Mayo Clinic News Network

The news release notes the Mayo Clinic cares for over 1000 pancreatic cancer patients each year. According to the American Cancer Society, over 57,000 Americans are diagnosed with pancreatic cancer and 47,000 will die from it this year.

News Update:  COVID-19: Weekly Deaths in MN Highest in Almost 4 Months